Home Newsletters Intestinal Cell News Blockade of CHRNB2 Signaling with a Therapeutic Monoclonal Antibody Attenuates the Aggressiveness...

Blockade of CHRNB2 Signaling with a Therapeutic Monoclonal Antibody Attenuates the Aggressiveness of Gastric Cancer Cells

0
Investigators generated gene knockouts through genome editing, performed RNA interference-mediated knockdown of gene expression, and ectopically expressed CHRNB2 in gastric cancer cells.
[Oncogene]
7992332 {7992332:F9NPJWP8} apa 50 1 165240 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Abstract
Exit mobile version